MedTrace Logo

Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2

NCT03296826 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-02-03

No results posted yet for this study

Summary

To determine the incidence and risk factors in the development of ovarian, fallopian tube, and peritoneal cancers in Japanese women carrying Breast Cancer Susceptibility Gene (BRCA)1/2 variants.

Conditions

  • BRCA1 and/or BRCA2 Variant Carriers
  • Ovarian Carcinoma
  • Fallopian Tube Carcinoma
  • Peritoneal Carcinoma

Sponsors & Collaborators

  • Okayama University

    collaborator OTHER

  • Japanese Gynecologic Oncology Group

    collaborator OTHER

  • Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

    lead OTHER

Principal Investigators

  • Akira Hirasawa, M.D., Ph.D. · Okayama University

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-08
Primary Completion
2032-03-31
Completion
2032-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03296826 on ClinicalTrials.gov